Archive: October 17, 2007

Reality is in the Results, and It Is No Surprise: Your ASP Tallies

Comments

In a recent Neltner News article, we asked for you to complete our short ASP “worksheet”. We’ve had several responses from oncology/hematology practices, comparing what they are paying to the Medicare allowable. The results? No surprise: most physicians are paying way too much. We will continue to update this as we get more data from hematologists/oncologists across the country. Now that you see the data, is it reality or myth…

Read More

Procrit and Aranesp: CMS Denies Reimbursement with New Policy

Comments

The Centers for Medicare & Medicaid Services (CMS) recently implemented a change in the coverage of two necessary drugs used in conjunction with the treatment of cancer. Procrit and Aranesp are given to cancer patients who suffer from anemia due to low red blood cell counts as a result of chemotherapy. These drugs have been used successfully in accordance with current Federal Drug Administration (FDA) regulations in relieving the fatigue…

Read More